PHARMA

0.335

(%)

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2021

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2021
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2021
The figures have not been audited

Attachments

Q3 2021 Bursa Announcement.pdf
543.7 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2021
30 Sep 2020
30 Sep 2021
30 Sep 2020
$$'000
$$'000
$$'000
$$'000
1 Revenue
2,132,675
624,804
4,103,297
2,090,488
2 Profit/(loss) before tax
98,219
4,093
151,987
49,299
3 Profit/(loss) for the period
50,324
1,294
87,040
33,316
4 Profit/(loss) attributable to ordinary equity holders of the parent
49,835
1,442
86,675
33,820
5 Basic earnings/(loss) per share (Subunit)
3.81
0.11
6.62
2.59
6 Proposed/Declared dividend per share (Subunit)
2.00
0.30
4.30
2.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.2990
0.2580

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 19 Nov 2021
Category Financial Results
Reference Number FRA-18112021-00001